Expression of Taurine Transporter (TauT) is Modulated by Heat Shock Factor 1 (HSF1) in Motor Neurons of ALS

[1]  J. Mendell,et al.  Astrocytes from Familial and Sporadic ALS Patients are Toxic to Motor Neurons , 2011, Nature Biotechnology.

[2]  Jang-Yen Wu,et al.  Taurine protection of PC12 cells against endoplasmic reticulum stress induced by oxidative stress , 2010, Journal of Biomedical Science.

[3]  N. Kowall,et al.  Differential regulation of neuronal and inducible nitric oxide synthase (NOS) in the spinal cord of mutant SOD1 (G93A) ALS mice. , 2009, Biochemical and biophysical research communications.

[4]  N. Kowall,et al.  Motor neuronal protection by L-arginine prolongs survival of mutant SOD1 (G93A) ALS mice. , 2009, Biochemical and biophysical research communications.

[5]  J. Trojanowski,et al.  Establishment of a cell model of ALS disease: Golgi apparatus disruption occurs independently from apoptosis , 2008, Biotechnology Letters.

[6]  P. Altevogt,et al.  Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis , 2007, Neuroscience Letters.

[7]  R. Ferrante,et al.  Antioxidants modulate mitochondrial PKA and increase CREB binding to D-loop DNA of the mitochondrial genome in neurons. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G. Carter,et al.  Current pharmacological management of amyotropic lateral sclerosis and a role for rational polypharmacy , 2004, Expert opinion on pharmacotherapy.

[9]  J. Rothstein.  Of mice and men: Reconciling preclinical ALS mouse studies and human clinical trials , 2003, Annals of neurology.

[10]  Z. Stelmasiak,et al.  Plasma amino acids concentration in amyotrophic lateral sclerosis patients , 2003, Amino Acids.

[11]  R. Takahashi,et al.  Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis , 2002, Journal of neurochemistry.

[12]  H. Takanaga,et al.  Regulation of taurine transport at the blood–brain barrier by tumor necrosis factor‐α, taurine and hypertonicity , 2002, Journal of neurochemistry.

[13]  M. Bitoun,et al.  Gene expression of the transporters and biosynthetic enzymes of the osmolytes in astrocyte primary cultures exposed to hyperosmotic conditions , 2000, Glia.

[14]  M. Bitoun,et al.  Gene expression of taurine transporter and taurine biosynthetic enzymes in brain of rats with acute or chronic hyperosmotic plasma. A comparative study with gene expression of myo-inositol transporter, betaine transporter and sorbitol biosynthetic enzyme. , 2000, Brain research. Molecular brain research.

[15]  Guoyao Wu,et al.  Arginine metabolism: nitric oxide and beyond. , 1998, The Biochemical journal.

[16]  L. Bruijn,et al.  Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. , 1998, Science.

[17]  D. McMillan,et al.  Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. , 1998, Circulation research.

[18]  D. Borchelt,et al.  ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions , 1997, Neuron.

[19]  A. Levey,et al.  Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis , 1995, Annals of neurology.

[20]  D. Borchelt,et al.  An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria , 1995, Neuron.

[21]  M. Aschner,et al.  Potassium and Taurine Release Are Highly Correlated with Regulatory Volume Decrease in Neonatal Primary Rat Astrocyte Cultures , 1994, Journal of neurochemistry.

[22]  M. Gurney,et al.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.

[23]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[24]  T. Branchek,et al.  Cloning and expression of a high affinity taurine transporter from rat brain. , 1992, Molecular pharmacology.

[25]  G. P. Martin,et al.  Bile Salt‐ and Lysophosphatidylcholine‐induced Membrane Damage in Human Erythrocytes , 1992, The Journal of pharmacy and pharmacology.

[26]  T. Tabira,et al.  Neuroblastoma × spinal cord (NSC) hybrid cell lines resemble developing motor neurons , 1992, Developmental dynamics : an official publication of the American Association of Anatomists.

[27]  A. Plaitakis,et al.  The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis , 1988, Annals of neurology.

[28]  S. Nelson,et al.  A Possible Role for Taurine in Osmoregulation Within the Brain , 1988, Journal of neurochemistry.

[29]  Jang-Yen Wu,et al.  Is taurine a neurotransmitter in rabbit retina? , 1985, Brain Research.

[30]  Y. Yoshino,et al.  Free amino acids in motor cortex of amyotrophic lateral sclerosis , 1979, Experientia.

[31]  P. Mcgeer,et al.  Pharmacologic Approaches to the Treatment of Amyotrophic Lateral Sclerosis , 2012, BioDrugs.

[32]  A. Ludolph,et al.  Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.

[33]  Guoyao Wu,et al.  Analysis of citrulline, arginine, and methylarginines using high-performance liquid chromatography. , 2008, Methods in enzymology.

[34]  M. Mozaffari,et al.  Effects of dietary salt and fat on taurine excretion in healthy and diseased rats. , 2006, Advances in experimental medicine and biology.

[35]  B. Citron,et al.  Prospects for the Pharmacotherapy of Amyotrophic Lateral Sclerosis , 2003, CNS drugs.

[36]  M. Bitoun,et al.  Gene expression of taurine transporter and taurine biosynthetic enzymes in hyperosmotic states: a comparative study with the expression of the genes involved in the accumulation of other osmolytes. , 2000, Advances in experimental medicine and biology.

[37]  M. Gurney,et al.  Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase. , 1996, Pathologie-biologie.

[38]  S. Dahrouge,et al.  Evaluation of the spinal cord neuron X neuroblastoma hybrid cell line NSC-34 as a model for neurotoxicity testing. , 1993, Neurotoxicology.

[39]  R J Huxtable,et al.  Physiological actions of taurine. , 1992, Physiological reviews.

[40]  Y. Yoshino,et al.  [Free amino-acids in the human spinal cord--analysis of anterior, posterior columns and anterior, lateral and posterior funiculi]. , 1976, Rinshō shinkeigaku Clinical neurology.